Hjem
Christian Beislands bilde

Christian Beisland

Professor
  • E-postChristian.Beisland@uib.no
  • Telefon+47 55 97 29 02
  • Besøksadresse
    Haukeland Universitetssykehus Laboratoriebygget, 7. etg. Heis øst
  • Postadresse
    Postboks 7804
    5020 Bergen
Vitenskapelig artikkel
  • Vis forfatter(e) 2021. The levels of IL-6 and soluble IL-33R are increased in the renal vein during surgery for clear cell renal cell carcinoma. Cytokine. 1-10.
  • Vis forfatter(e) 2021. The epithelial–mesenchymal transition regulators Twist, Slug, and Snail are associated with aggressive tumour features and poor outcome in prostate cancer patients. The journal of pathology. Clinical research. 253-270.
  • Vis forfatter(e) 2021. Prevalence, disease-free, and overall survival of contemporary patients with renal cell carcinoma eligible for adjuvant checkpoint inhibitor trials. Clinical Genitourinary Cancer. 1-8.
  • Vis forfatter(e) 2021. Preoperative predictors of pathological tumour stage and prognosis may be used when selecting candidates for intensified treatment in upper tract urothelial carcinoma. Scandinavian Journal of Urology. 100-107.
  • Vis forfatter(e) 2021. Higher than expected and significantly increasing incidence of upper tract urothelial carcinoma. A population based study. World Journal of Urology. 1-7.
  • Vis forfatter(e) 2020. The biological context of c-reactive protein as a prognostic marker in renal cell carcinoma: Studies on the acute phase cytokine profile. Cancers. 1-18.
  • Vis forfatter(e) 2020. Serum levels of the IL-6 family of cytokines predict prognosis in renal cell carcinoma (RCC). Cancer Immunology and Immunotherapy. 1-12.
  • Vis forfatter(e) 2020. Personality and educational level determine self-reported health-related quality-of-life and distress in patients with renal tumors awaiting radical surgery. Scandinavian Journal of Urology. 304-312.
  • Vis forfatter(e) 2020. Non-metastatic prostate cancer: rationale for conservative treatment and impact on disease-related morbidity and mortality in the elderly. Scandinavian Journal of Urology. 105-109.
  • Vis forfatter(e) 2020. Magnetic resonance radiomics for prediction of extraprostatic extension in non-favorable intermediate- and high-risk prostate cancer patients. Acta Radiologica. 1570-1579.
  • Vis forfatter(e) 2020. Assessing extraprostatic extension by mpMRI of the prostate: Mehralivand’s EPE grade or EPE Likert score? Radiology: Imaging Cancer.
  • Vis forfatter(e) 2019. Tumour architecture, grade and location remain predictors of non-organ-confined upper tract urothelial carcinoma at time of radical nephroureterectomy: results from a multicenter Norwegian external validation study. World Journal of Urology. 717-723.
  • Vis forfatter(e) 2019. Transcriptome-proteome integration of archival human renal cell carcinoma biopsies enables identification of molecular mechanisms. American Journal of Physiology - Renal Physiology (AJP).
  • Vis forfatter(e) 2019. Increased use of cross-sectional imaging for follow-up does not improve post-recurrence survival of surgically treated initially localized R.C.C.: results from a European multicenter database (R.E.C.U.R.). Scandinavian Journal of Urology. 14-20.
  • Vis forfatter(e) 2019. FOXC2 expression and epithelial–mesenchymal phenotypes are associated with castration resistance, metastasis and survival in prostate cancer. The journal of pathology. Clinical research. 272-286.
  • Vis forfatter(e) 2019. Elevated plasma interleukin 6 predicts poor response in patients treated with sunitinib for metastatic clear cell renal cell carcinoma. Cancer Treatment and Research Communications. 1-5.
  • Vis forfatter(e) 2018. Use of venous-thrombotic-embolic prophylaxis in patients undergoing surgery for renal tumors: a questionnaire survey in the Nordic countries (The NORENCA-2 study). Research and reports in urology. 181-187.
  • Vis forfatter(e) 2018. Tumour cell expression of interleukin 6 receptor a is associated with response rates in patients treated with sunitinib for metastatic clear cell renal cell carcinoma. The journal of pathology. Clinical research. 114-123.
  • Vis forfatter(e) 2018. Sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma. New England Journal of Medicine. 417-427.
  • Vis forfatter(e) 2018. Novel protein signatures suggest progression to muscular invasiveness in bladder cancer. PLOS ONE. 1-15.
  • Vis forfatter(e) 2018. National Norwegian Practice Patterns for Surgical Treatment of Kidney Cancer Tumors ≤7cm: Adherence to Changes in Guidelines May Improve Overall Survival. European Urology Oncology (EUO). 252-261.
  • Vis forfatter(e) 2018. Long-term outcomes of follow-up for initially localised clear cell renal cell carcinoma: RECUR database analysis. European Urology Focus. 857-866.
  • Vis forfatter(e) 2018. Intensive imaging-based follow-up of surgically treated localised renal cell carcinoma does not improve post-recurrence survival: Results from a European multicentre database (RECUR). European Urology. 1-4.
  • Vis forfatter(e) 2018. Intensity-based volumetric registration of magnetic resonance images and whole-mount sections of the prostate. Computerized Medical Imaging and Graphics. 24-30.
  • Vis forfatter(e) 2018. Fine needle aspirates of kidneys: A promising tool for RNA sequencing in native and transplanted kidneys. BMC Nephrology. 1-9.
  • Vis forfatter(e) 2018. External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma. World Journal of Urology. 1-8.
  • Vis forfatter(e) 2018. Expanding the utilization of formalin-fixed, paraffin-embedded archives: Feasibility of miR-Seq for disease exploration and biomarker development from biopsies with clear cell renal cell Carcinoma. International Journal of Molecular Sciences. 1-18.
  • Vis forfatter(e) 2018. Dictionary-based through-plane interpolation of prostate cancer T2-weighted MR images. Signal Processing - Algorithms, Architectures, Arrangements, and Applications Conference Proceedings, SPA. 168-173.
  • Vis forfatter(e) 2018. CRF-Based clustering of pharmacokinetic curves from dynamic contrast-enhanced MR images. Signal Processing - Algorithms, Architectures, Arrangements, and Applications Conference Proceedings, SPA. 174-179.
  • Vis forfatter(e) 2017. Use of diagnostic biopsies in kidney tumors. Scandinavian Journal of Urology. 185-192.
  • Vis forfatter(e) 2017. Rule-based data-driven approach for computer aided diagnosis of the peripheral zone prostate cancer from multiparametric MRI: Proof of concept. Signal Processing - Algorithms, Architectures, Arrangements, and Applications Conference Proceedings, SPA. 90-95.
  • Vis forfatter(e) 2017. Reconstruction of high-resolution T2W MR images of the prostate using maximum a posteriori approach and Markov random field regularization. Signal Processing - Algorithms, Architectures, Arrangements, and Applications Conference Proceedings, SPA. 96-99.
  • Vis forfatter(e) 2017. Real-life use of diagnostic biopsies before treatment of kidney cancer: results from a Norwegian population-based study. Scandinavian Journal of Urology. 38-44.
  • Vis forfatter(e) 2017. Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma. BMC Urology. 1-11.
  • Vis forfatter(e) 2017. Overall Survival in Renal Cell Carcinoma after Introduction of Targeted Therapies: A Norwegian Population-Based Study. OncoTargets and Therapy. 371-385.
  • Vis forfatter(e) 2017. Optimising preoperative risk stratification tools for prostate cancer using mpMRI. European Radiology. 1016-1026.
  • Vis forfatter(e) 2017. Incidental detection of renal cell carcinoma. Scandinavian Journal of Urology. 178-184.
  • Vis forfatter(e) 2017. Contemporary treatment of renal tumors: a questionnaire survey in the Nordic countries (the NORENCA-I study). Scandinavian Journal of Urology. 360-366.
  • Vis forfatter(e) 2017. Clear cell renal cell carcinoma is linked to epithelial-to-mesenchymal transition and to fibrosis. Physiological Reports. 1-18.
  • Vis forfatter(e) 2016. Trends in stage-specific incidence of prostate cancer in Norway, 1980–2010: a population-based study. BJU International. 547-555.
  • Vis forfatter(e) 2016. Transcriptome sequencing (RNAseq) enables utilization of formalin-fixed, paraffin-embedded biopsies with clear cell renal cell carcinoma for exploration of disease biology and biomarker development. PLOS ONE.
  • Vis forfatter(e) 2016. RNA extraction for RNA sequencing of archival renal tissues. Scandinavian Journal of Clinical and Laboratory Investigation. 426-434.
  • Vis forfatter(e) 2016. Postoperative 30-day mortality rates for kidney cancer are dependent on hospital surgical volume: results from a Norwegian population-based study. European Urology Focus. 300-307.
  • Vis forfatter(e) 2016. Nephron Sparing Surgery Associated with Better Survival Than Radical Nephrectomy in Patients Treated for Unforeseen Benign Renal Tumors. Urology. 117-123.
  • Vis forfatter(e) 2016. Grading of urothelial carcinoma of the upper urinary tract according to the World Health Organization/International Society of Urological Pathology classification from 2004 is a valuable tool when considering whether a patient is suitable for endoscopic treatment. Scandinavian Journal of Urology. 298-304.
  • Vis forfatter(e) 2016. Development of a disease-specific health-related quality of life (HRQoL) questionnaire intended to be used in conjunction with the general European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) in renal cell carcinoma patients. Acta Oncologica. 349-356.
  • Vis forfatter(e) 2016. Development and confirmation of potential gene classifiers of human clear cell renal cell carcinoma using next-generation RNA sequencing. Scandinavian Journal of Urology. 452-462.
  • Vis forfatter(e) 2016. A prospective risk-stratified follow-up programme for radically treated renal cell carcinoma patients: evaluation after eight years of clinical use. World Journal of Urology. 1087-1099.
  • Vis forfatter(e) 2016. A positive Real-Time Elastography (RTE) combined with a Prostate Cancer Gene 3 (PCA3) score above 35 convey a high probability of intermediate- or high-risk prostate cancer in patient admitted for primary biopsy. BMC Urology. 1-8.
  • Vis forfatter(e) 2015. Prostate cancer antigen-3 (PCA3) and PCA3-based nomograms in the diagnosis of prostate cancer: an external validation of Hansen's nomogram on a Norwegian cohort. Scandinavian Journal of Urology. 8-15.
  • Vis forfatter(e) 2015. Preoperative high levels of serum vascular endothelial growth factor are a prognostic marker for poor outcome after surgical treatment of renal cell carcinoma. Scandinavian Journal of Urology. 388-394.
  • Vis forfatter(e) 2015. Health-related quality of life, personality and choice of coping are related in renal cell carcinoma patients. Scandinavian Journal of Urology. 282-289.
  • Vis forfatter(e) 2015. Contemporary external validation of the Leibovich model for prediction of progression after radical surgery for clear cell renal cell carcinoma. Scandinavian Journal of Urology. 205-210.
  • Vis forfatter(e) 2015. 1.5-T multiparametric MRI using PI-RADS: a region by region analysis to localize the index-tumor of prostate cancer in patients undergoing prostatectomy. Acta Radiologica. 500-511.
  • Vis forfatter(e) 2014. Langtidsoverlevelse etter behandling av overgangsepitelkarsinom i ureter og nyrebekken. Kirurgen. 113-116.
  • Vis forfatter(e) 2014. Health-related quality of life in long-term survivors after renal cancer treatment. Scandinavian Journal of Urology and Nephrology. 52-64.
  • Vis forfatter(e) 2014. A positive real-time elastography is an independent marker for detection of high-risk prostate cancers in the primary biopsy setting. BJU International. E90-E97.
  • Vis forfatter(e) 2013. Incidentally detected renal cell carcinomas are highly associated with comorbidity and mortality unrelated to renal cell carcinoma. Scandinavian Journal of Urology and Nephrology. 462-471.
  • Vis forfatter(e) 2013. Does a surgeon’s annual radical prostatectomy volume predict the risk of positive surgical margins and urinary incontinence at one-year follow-up? Findings from a prospective national study. Scandinavian Journal of Urology and Nephrology. 92-100.
  • Vis forfatter(e) 2012. Ureterskadar og handsaming av desse. Kirurgen. 217-219.
  • Vis forfatter(e) 2012. Testikkeltorsjoner behandlet ved Haukeland universitetssjukehus i årene 2000-2008. Kirurgen. 212-215.
  • Vis forfatter(e) 2012. Obesity is associated with an improved cancer-specific survival, but an increased rate of postoperative complications after surgery for renal cell carcinoma. Scandinavian Journal of Urology and Nephrology. 348-357.
  • Vis forfatter(e) 2012. Combination of real-time elastography and urine prostate cancer gene 3 (PCA3) detects more than 97 % of significant prostate cancers. Scandinavian Journal of Urology and Nephrology. 211-216.
  • Vis forfatter(e) 2009. Observation should be considered as an alternative in management of renal masses in lder and comorbid patients. European Urology. 1419-1429.
  • Vis forfatter(e) 2006. Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study. BJU International. 698-702.
  • Vis forfatter(e) 2004. Vitiligo--an autoimmune side-effect of intravesical bacillus Calmette-Guerin instillation? Scandinavian Journal of Urology and Nephrology. 182-183.
  • Vis forfatter(e) 2004. Presumed radically treated renal cell carcinoma--recurrence of the disease and prognostic factors for subsequent survival. Scandinavian Journal of Urology and Nephrology. 299-305.
  • Vis forfatter(e) 2004. Natural and clinical course of renal cell carcinoma--better prospect for the patients. Scandinavian Journal of Surgery. 97-101.
  • Vis forfatter(e) 2002. Nyrekreft - en retrospektiv undersøkelse av 368 pasienter. Tidsskrift for Den norske legeforening. 2431-2435.
Faglig foredrag
  • Vis forfatter(e) 2015. Post ASCO GU 2015 - Nyre/ Blære; Hva er nytt!
Vitenskapelig foredrag
  • Vis forfatter(e) 2019. Personality and choice of coping are important for self-reported health-related quality of life in patients with renal tumors prior to radical surgery.
  • Vis forfatter(e) 2019. Level of distress is closely related to personality and choice of coping in patients with renal tumors prior to radical surgery.
  • Vis forfatter(e) 2019. Cytoreductive and palliative renal surgery.
  • Vis forfatter(e) 2013. Psykometrisk validering av et diagnosespesifikt livskvalitets- skjema (HRQoL,) ment brukt sammen med det generelle EORTC livskvalitests- skjemaet (QLQ) på nyrekreft-pasienter.
  • Vis forfatter(e) 2013. Psychometric validation of a disease-specific Health Related Quality of Life (HRQoL) questionnaire intended to be used in conjunction with the general European Organization of Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) in Renal Cell Carcinoma patients.
  • Vis forfatter(e) 2012. Radiologisk vs. patologisk størrelse av nyrecellecarcinomer i stadium I og II - betydning for stadiumspesifikk overlevelse.
  • Vis forfatter(e) 2012. Radikale prostatektomier ved Haukeland universitetssjukehus 2010-2012.
  • Vis forfatter(e) 2012. Pyeloplastikk på barn - erfaringer fra Haukeland universitetssjukehus 2001-2011.
  • Vis forfatter(e) 2012. Oppstart med behandling av postprostatektomi inkontinens (PPI) ved Haukeland universitetssjukehus.
  • Vis forfatter(e) 2012. Læringskurven for RALP ved Haukeland universitetssjukehus 2010-2012.
  • Vis forfatter(e) 2012. Lymfekjerteltoilette (PLND) ved radikale prostatektomier ved Haukeland universitetssjukehus 2010-2012.
  • Vis forfatter(e) 2012. Evaluering av oppfølgningsprogrammet for nyrekreft (RCC)ved Haukeland universitetssjukehus.
  • Vis forfatter(e) 2010. Real time elastografi ved cancer prostatae.
  • Vis forfatter(e) 2010. Preliminære resultater av PCA3 måling i urin hos pasienter med cancer prostatae.
  • Vis forfatter(e) 2010. Er preoperativ MR-prostata nyttig for å avklare korrekt T-stadium forut for kirurgi?
  • Vis forfatter(e) 2010. Er MR-prostata nyttig for å avklare videre oppfølgningsbehov hos pasienter med 2 eller flere negative biopsiserier?
  • Vis forfatter(e) 2002. Overlevelse etter metastasering fra nyrecelle carcinom (RCC) - hvilke prognostiske faktorer har betydning?
  • Vis forfatter(e) 2002. Innføring av laparoskopisk PLND ved cancer prostatae som standard operasjonsmetode - gir det noen gevinst?
  • Vis forfatter(e) 2002. Genital selvmutilering (GSM) - ren skjær galskap eller .. ?
  • Vis forfatter(e) 1991. Ileal Conduit ad modum Bricker. Complications and Quality of Life. .
Leder
  • Vis forfatter(e) 2020. Cytoreductive nephrectomy in primary metastatic clear cell renal cell carcinoma. Scandinavian Journal of Urology.
Leserinnlegg
  • Vis forfatter(e) 2013. Untitled. American Journal of Clinical Oncology. 423-423.
Brev til redaktøren
  • Vis forfatter(e) 2013. Letter to the Editor. American Journal of Clinical Oncology. 423-423.
Doktorgradsavhandling
  • Vis forfatter(e) 2019. Late-Stage Prostate Cancer and Prostate Cancer Mortality. A Population-Based Study.
  • Vis forfatter(e) 2018. A population based study on Kidney Cancer in Norway (2008 - 2013).
  • Vis forfatter(e) 2006. Epidemiological and Clinical Aspects in Diagnosis and Treatment of Renal Cell Carcinoma.
Sammendrag/abstract
  • Vis forfatter(e) 2016. Perioperative 30-day mortality rates are dependent on hospital surgical volume – results from a Norwegian population based study on surgical treatment for renal cell carcinoma. European Urology. Supplement. e520.
  • Vis forfatter(e) 2016. Changes in surgical treatment of modalities for renal cell carcinoma ≤ 7 cm – a Norwegian population based study 2008-2013. European Urology. Supplement. e1089.
  • Vis forfatter(e) 2013. Survival after treatment for urothelial carcinoma in the upper urinary tract. Results of the final analysis-25 years postsurgery. Scandinavian Journal of Urology and Nephrology. 33-33.
  • Vis forfatter(e) 2013. Serum VEGF in patients with renal tumours and low contrast enhancement on ct can be used to predict survival and recurrence. Scandinavian Journal of Urology and Nephrology. 32-33.
  • Vis forfatter(e) 2013. Health related quality of life (HRQoL), personality and choice of coping is associated in renal cell carcinoma patients. Scandinavian Journal of Urology and Nephrology. 33-34.
Poster
  • Vis forfatter(e) 2019. Helse og livskvalitet hos kognitivt intakte elektive kreftpasienter over 80 år .
  • Vis forfatter(e) 2018. Fine needle aspirates of kidneys are usable for RNA sequencing like regular core biopsies.
  • Vis forfatter(e) 2018. Expanding the utilization of formalin-fixed, paraffin-embedded archives: Feasability of miRNA-sequencing for disease exploration and biomarker development from biopsies with clear cell renal cell carcinoma.
  • Vis forfatter(e) 2016. Detection and Validation of Epithelial-to-Mesenchymal Transition(EMT) with Increased Expression of Axl and MMP-14 in Renal Cell Carcinoma.
  • Vis forfatter(e) 2015. C-reactive protein as a predictive marker of response to sunitinib treatment in metastatic clear cell renal cell carcinoma.
  • Vis forfatter(e) 2014. Registration of multiparametric MRI and whole-mount sections of the prostate.
  • Vis forfatter(e) 2014. Registration of multiparametric MRI and whole-Mount sections prostate.
  • Vis forfatter(e) 2013. Health related quality of life (HRQoL) personality and choice of coping is associated in renal cell carcinoma patinets.
Vitenskapelig oversiktsartikkel/review
  • Vis forfatter(e) 2014. Traumatiske skader i nyra – ei orientering for dei utan spesialistkompetanse. Kirurgen. 119-123.
  • Vis forfatter(e) 2008. Radikal behandling av Cancer Renis – En oversikt for kirurger. Kirurgen. 12-15.

Se fullstendig oversikt over publikasjoner i CRIStin.